Sara A Monaghan

  • 315 Citations
  • 6 h-Index
20032019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Sara A Monaghan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
Down-Regulation Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Neutropenia Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Cytogenetics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

  • 315 Citations
  • 6 h-Index
  • 17 Article
  • 1 Chapter
  • 1 Editorial

Harmonization of Training, Training Requirements, Board Certification, and Practice of Hematopathology

Swerdlow, S. H., Monaghan, S. A., Douglas, A. R., Johnson, K. & Johnson, R. L., Oct 7 2019, In : American Journal of Clinical Pathology. 152, 5, p. 625-637 13 p.

Research output: Contribution to journalArticle

Certification
Bone Marrow
Pathology
Graduate Medical Education
Accreditation
1 Citation (Scopus)

Immunomodulatory drugs downregulate IKZF1 leading to expansion of hematopoietic progenitors with concomitant block of megakaryocytic maturation

Liu, A., Li, S., Donnenberg, V., Fu, J., Gollin, S. M., Ma, H., Lu, C., Stolz, D. B., Mapara, M. Y., Monaghan, S. A. & Lentzsch, S., Sep 30 2018, In : Haematologica. 103, 10, p. 1688-1697 10 p.

Research output: Contribution to journalArticle

Down-Regulation
Pharmaceutical Preparations
Thrombocytopenia
Megakaryocytes
Hematologic Neoplasms
5 Citations (Scopus)

Venetoclax in a patient with a blastic plasmacytoid dendritic-cell neoplasm

Agha, M. E., Monaghan, S. A. & Swerdlow, S. H., Oct 11 2018, In : New England Journal of Medicine. 379, 15, p. 1479-1481 3 p.

Research output: Contribution to journalEditorial

Dendritic Cells
Neoplasms
4-(4-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl)methyl)piperazin-1-yl)-N-((3-nitro-4-((tetrahydro-2H-pyran-4-ylmethyl)amino)phenyl)sulfonyl)-2-(1H-pyrrolo(2,3-b)pyridin-5-yloxy)benzamide
12 Citations (Scopus)

Activating JAK2 mutants reveal cytokine receptor coupling differences that impact outcomes in myeloproliferative neoplasm

Yao, H., Ma, Y., Hong, Z., Zhao, L., Monaghan, S. A., Hu, M. C. & Huang, J-S., Oct 1 2017, In : Leukemia. 31, 10, p. 2122-2131 10 p.

Research output: Contribution to journalArticle

TYK2 Kinase
Janus Kinase 2
Cytokine Receptors
Neoplasms
Exons

Acute Myeloid Leukemia With a Rare t(7;14)(q21;q32) and Trisomy 4 With Poor Clinical Outcome: A Case Report

Jabbar, S. B., Monaghan, S., Chen, W., Koduru, P. & Kumar, K., Nov 8 2017, In : Laboratory Medicine. 48, 4, p. 376-380 5 p.

Research output: Contribution to journalArticle

Flow cytometry
Trisomy
Acute Myeloid Leukemia
Bone
Cytogenetics